Eva Escudero‐López

Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma

Carmen Álvarez‐Fernández, Laura Escribà-García, AC Caballero et al. · Clinical & Translational Immunology · 2021 · 33 citations · Full text

Medicine, Immunology, Oncology +17

BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine

Omodele Ashiru, Gloria Esteso, Eva M. García‐Cuesta et al. · Cancers · 2019 · 22 citations · Full text

Medicine, Immunology, Oncology +17

Phase 1 Clinical Trial of Memory-Enriched Academic HSP-CAR30 for the Treatment of Relapsed/Refractory Hodgkin Lymphoma and CD30+ T-Cell Lymphoma: Clinical and Biological Studies

Ana Carolina Carolina Caballero Gonzalez, Laura Escribà-García, Rosanna Montserrat et al. · Blood · 2022 · 13 citations

Life Sciences, Immunology, Oncology +15

HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma

A Caballero, Cristina Ujaldón‐Miró, Paula Pujol‐Fernández et al. · Blood · 2025 · 12 citations

Life Sciences, Immunology, Oncology +17